Stay updated on Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.

Latest updates to the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedAdded an informational Notice banner about a lapse in government funding and updated to Revision: v3.4.1; the change does not modify study data or eligibility details.SummaryDifference0.3%

- Check10 days agoChange DetectedUI/footer text updates include adding a 'Show glossary' control and standardizing capitalization for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The revision label updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision line updated from v3.3.3 to v3.3.4 in the page footer. This appears to be a minor site version update with no visible changes to content or functionality.SummaryDifference0.0%

- Check46 days agoChange DetectedThe new Locations section now lists Alabama, Arizona, District of Columbia, Maryland, Massachusetts, Michigan, Tennessee, and Texas. The former state-specific location entries were removed.SummaryDifference0.7%

- Check75 days agoChange DetectedThe PubMed publication note text was updated to say publications are automatically filled in from PubMed, replacing the previous wording; the page revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page no longer displays the government funding/operating status notice, and this deletion does not alter the study details, eligibility criteria, enrollment, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.